Abu-Elheiga, L, Matzuk, MM, Abo-Hashema, KA & Wakil, SJ (2001) Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science 291, 2613–2616.
Cai, D, Yuan, M, Frantz, DF, Melendez, PA, Hansen, L, Lee, J & Shoelson, SE (2005) Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 11, 183–190.
Chakravarthy, MV, Pan, Z, Zhu, Y, Tordjman, K, Schneider, JG, Coleman, T, Turk, J & Semenkovich, CF (2005) ‘New’ hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. Cell Metab 1, 309–322.
Desvergne, B, Michalik, L & Wahli, W (2006) Transcriptional regulation of metabolism. Physiol Rev 86, 465–514.
Eberle, D, Hegarty, B, Bossard, P, Ferre, P & Foufelle, F (2004) SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 86, 839–848.
Ellis, BA, Poynten, A, Lowy, AJ, Furler, SM, Chisholm, DJ, Kraegen, EW & Cooney, GJ (2000) Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. Am J Physiol Endocrinol Metab 279, E554–E560.
Finck, BN (2006) Effects of PPARalpha on cardiac glucose metabolism: a transcriptional equivalent of the glucose-fatty acid cycle? Expert Rev Cardiovasc Ther 4, 161–171.
Frayn, KN (2002) Adipose tissue as a buffer for daily lipid flux. Diabetologia 45, 1201–1210.
Frayn, KN (2003) The glucose-fatty acid cycle: a physiological perspective. Biochem Soc Trans 31, 1115–1119.
Garland, PB, Newsholme, EA & Randle, PJ (1962) Effect of fatty acids, ketone bodies, diabetes and starvation on pyruvate metabolism in rat heart and diaphragm muscle. Nature 195, 381–383.
Gromada, J (2006) The free fatty acid receptor GPR40 generates excitement in pancreatic beta-cells. Endocrinology 147, 672–673.
Hegarty, BD, Furler, SM, Ye, J, Cooney, GJ & Kraegen, EW (2003) The role of intramuscular lipid in insulin resistance. Acta Physiol Scand 178, 373–383.
Holness, MJ, Fryer, LG & Sugden, MC (1997) Endocrine and nutritional modulation of glucose disposal and storage in muscle. Biochem Soc Trans 25, 1–7.
Kersten, S, Seydoux, J, Peters, JM, Gonzalez, FJ, Desvergne, B & Wahli, W (1999) Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest 103, 1489–1498.
Kim, JK, Kim, YJ, Fillmore, JJ, Chen, Y, Moore, I, Lee, J, Yuan, M, Li, ZW, Karin, M, Perret, P, Shoelson, SE & Shulman, GI (2001) Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 108, 437–446.
Koyama, K, Chen, G, Lee, Y & Unger, RH (1997) Tissue triglycerides, insulin resistance, and insulin production: implications for hyperinsulinemia of obesity. Am J Physiol 273, E708–E713.
Leone, TC, Weinheimer, CJ & Kelly, DP (1999) A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci USA 96, 7473–7478.
McGarry, JD (1998) Glucose-fatty acid interactions in health and disease. Am J Clin Nutr 67, 500S–504S.
Muoio, DM & Newgard, CB (2006) Obesity-related derangements in metabolic regulation. Annu Rev Biochem 75, 367–401.
Perseghin, G, Petersen, K & Shulman, GI (2003) Cellular mechanism of insulin resistance: potential links with inflammation. Int J Obes Relat Metab Disord 27, Suppl. 3, S6–S11.
Poitout, V & Robertson, RP (2002) Minireview: Secondary beta-cell failure in type 2 diabetes-a convergence of glucotoxicity and lipotoxicity. Endocrinology 143, 339–342.
Prentki, M, Vischer, S, Glennon, MC, Regazzi, R, Deeney, JT & Corkey, BE (1992) Malonyl-CoA and long chain acyl-CoA esters as metabolic coupling factors in nutrient-induced insulin secretion. J Biol Chem 267, 5802–5810.
Randle, PJ (1998) Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab Rev 14, 263–283.
Randle, PJ, Garland, PB, Hales, CN & Newsholme, EA (1963) The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1, 785–789.
Ruderman, NB, Saha, AK & Kraegen, EW (2003) Minireview: malonyl CoA, AMP-activated protein kinase, and adiposity. Endocrinology 144, 5166–5171.
Saha, AK & Ruderman, NB (2003) Malonyl-CoA and AMP-activated protein kinase: an expanding partnership. Mol Cell Biochem 253, 65–70.
Sugden, MC & Holness, MJ (2004) Potential role of peroxisome proliferator-activated receptor-alpha in the modulation of glucose-stimulated insulin secretion. Diabetes 53, Suppl. 1, S71–S81.
Sugden, MC & Holness, MJ (2006) Skeletal muscle lipid metabolism and the adipo-muscular axis. Future Lipidology 1, 153–162.
Summers, SA & Nelson, DH (2005) A role for sphingolipids in producing the common features of type 2 diabetes, metabolic syndrome X, and Cushing's syndrome. Diabetes 54, 591–602.
Thompson, AL & Cooney, GJ (2000) Acyl-CoA inhibition of hexokinase in rat and human skeletal muscle is a potential mechanism of lipid-induced insulin resistance. Diabetes 49, 1761–1765.
Zammit, VA (1999) The malonyl-CoA-long-chain acyl-CoA axis in the maintenance of mammalian cell function. Biochem J 343, 505–515.